Related references
Note: Only part of the references are listed.Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis (Publication with Expression of Concern. See vol. 114, 2022)
Hua Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Sangeeta Goswami et al.
NATURE MEDICINE (2020)
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto et al.
TRANSLATIONAL ONCOLOGY (2020)
TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition
Yangyang Xiao et al.
ONCOTARGETS AND THERAPY (2020)
Primary leiomyosarcoma of the uterine cervix: report of 4 cases, systematic review, and meta-analysis
Cigdem Kilic et al.
TUMORI JOURNAL (2020)
Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
Shuang Qin et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential
Reem Saleh et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Comparison of prognostic factors in different age groups and prognostic significance of neutrophil-lymphocyte ratio in patients with gastric cancer
Qiong Li et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells
Yizi Cong et al.
CHINESE JOURNAL OF CANCER RESEARCH (2020)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization (vol 175, pg 313, 2018)
Miguel F. Sanmamed et al.
CELL (2019)
Prognostic value of CD8+PD-1+immune infiltrates and PDCD1 gene expression in triple negative breast cancer
Joe Yeong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
Susu Han et al.
FRONTIERS IN ONCOLOGY (2019)
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
Jitka Fucikova et al.
CLINICAL CANCER RESEARCH (2019)
Altered expression of TIM-3, LAG-3, IDO, PD-L1, and CTLA-4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients
Hong Wang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Clinicopathological implications of TIM3+ tumor-infiltrating lymphocytes and the miR-455-5p/Galectin-9 axis in skull base chordoma patients
Jinpeng Zhou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas
Amanda R. Dancsok et al.
MODERN PATHOLOGY (2019)
The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
Inna M. Yasinska et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune gene expression in head and neck squamous cell carcinoma patients
Charlotte Lecerf et al.
EUROPEAN JOURNAL OF CANCER (2019)
Significance of TIM3 expression in cancer: From biology to the clinic
Cinzia Solinas et al.
SEMINARS IN ONCOLOGY (2019)
Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients
Qinchuan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
Xingming Zhang et al.
BMC CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The Clinicopathologic and Prognostic Value of Hypoxia-Inducible Factor-2 alpha in Cancer Patients: A Systematic Review and Meta-Analysis
Deqing Luo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma
Min Hee Hong et al.
SCIENTIFIC REPORTS (2019)
The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis
Susu Han et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis
Susu Han et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease
J. Zhao et al.
CURRENT MOLECULAR MEDICINE (2018)
Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer
Nicholas Borcherding et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Characterization of TIM-3 expression and its prognostic value in patients with surgically resected lung adenocarcinoma
Hang Su et al.
LUNG CANCER (2018)
Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis
Marra Aghajani et al.
THYROID (2018)
Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection
Fang Li et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Enterocolitis due to immune checkpoint inhibitors: a systematic review
Emilie Soularue et al.
GUT (2018)
Association between Tim-3 and Gal-9 expression and gastric cancer prognosis
Yangyang Wang et al.
ONCOLOGY REPORTS (2018)
A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
Jingjing Duan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer
Kyung Do Byun et al.
JOURNAL OF BREAST CANCER (2018)
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma
Li-Jie Ma et al.
THERANOSTICS (2018)
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
Elly Marcq et al.
ONCOIMMUNOLOGY (2017)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
Wenhui Ge et al.
TUMOR BIOLOGY (2017)
T-cell immunoglobulin and mucin domain-containing protein-3 and galectin-9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients
Nan Hou et al.
ONCOLOGY LETTERS (2017)
TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis
Yang Zhang et al.
ONCOTARGET (2017)
The immune system in cancer metastasis: friend or foe?
Louise M. E. Janssen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
Junlong Wu et al.
SCIENTIFIC REPORTS (2017)
Immune Checkpoint Inhibitors: An Introduction to the Next-Generation Cancer Immunotherapy
Lucy Lee et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The immune system and cancer evasion strategies: therapeutic concepts
S. Muenst et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Association of atopic dermatitis with smoking: A systematic review and meta-analysis
Robert Kantor et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression
Yoshikane Kikushige et al.
CELL STEM CELL (2015)
Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation
Binh L. Phong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
T-Cell Immunoglobulin Mucin-3 Expression in Bladder Urothelial Carcinoma: Clinicopathologic Correlations and Association With Survival
Meng Yang et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas
Yoshihiro Komohara et al.
CANCER IMMUNOLOGY RESEARCH (2015)
TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
Gordon J. Freeman et al.
IMMUNOLOGICAL REVIEWS (2015)
Immune cell promotion of metastasis
Takanori Kitamura et al.
NATURE REVIEWS IMMUNOLOGY (2015)
HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis
Alberto Ocana et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
Yang Cao et al.
PLOS ONE (2013)
Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
Jing Jiang et al.
PLOS ONE (2013)
Ectopic Expression of TIM-3 in Lung Cancers A Potential Independent Prognostic Factor for Patients With NSCLC
Xuewei Zhuang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
Lishomwa C. Ndhlovu et al.
BLOOD (2012)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
HEGESMA: genome search meta-analysis and heterogeneity testing
E Zintzaras et al.
BIOINFORMATICS (2005)
Share Paper
